Thrive Capital, the venture firm that led Isomorphic Labs' first funding round last year, is set to lead the new financing, said the people, who spoke on condition of anonymity as the information is not public. Alphabet is also participating, one person said, though the round is not yet closed. Isomorphic Labs is one of a growing number of businesses attempting to apply advances in AI to speed up drug discoveries and cut the costs of such work, despite many failures from Silicon Valley to expand into health ...